Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
29 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Jyant Technologies, Inc. - Product Pipeline Review - 2016 Summary
Global Markets Direct's, 'Jyant Technologies, Inc. - Product Pipeline Review - 2016', provides an overview of the Jyant Technologies, Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Jyant Technologies, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Jyant Technologies, Inc. - The report provides overview of Jyant Technologies, Inc. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Jyant Technologies, Inc.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Jyant Technologies, Inc.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to buy
- Evaluate Jyant Technologies, Inc.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Jyant Technologies, Inc. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Jyant Technologies, Inc.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Jyant Technologies, Inc. Snapshot 5 Jyant Technologies, Inc. Overview 5 Key Information 5 Key Facts 5 Jyant Technologies, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Jyant Technologies, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Jyant Technologies, Inc. - Pipeline Products Glance 10 Jyant Technologies, Inc. - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Jyant Technologies, Inc. - Early Stage Pipeline Products 11 Preclinical Products/Combination Treatment Modalities 11 Jyant Technologies, Inc. - Drug Profiles 12 JT-02 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 alvocidib hydrochloride 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 cisplatin 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 JT-03 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 JT-04 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 JT-05 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 JT-06 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 JT-07 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 JT-08 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Peptide to Antagonize Leptin Receptor II for Breast Cancer 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 resveratrol 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Jyant Technologies, Inc. - Pipeline Analysis 23 Jyant Technologies, Inc. - Pipeline Products by Target 23 Jyant Technologies, Inc. - Pipeline Products by Route of Administration 24 Jyant Technologies, Inc. - Pipeline Products by Molecule Type 25 Jyant Technologies, Inc. - Pipeline Products by Mechanism of Action 26 Jyant Technologies, Inc. - Locations And Subsidiaries 27 Head Office 27 Appendix 28 Methodology 28 Coverage 28 Secondary Research 28 Primary Research 28 Expert Panel Validation 28 Contact Us 28 Disclaimer 29
List of Tables
Jyant Technologies, Inc., Key Information 5 Jyant Technologies, Inc., Key Facts 5 Jyant Technologies, Inc. - Pipeline by Indication, 2016 7 Jyant Technologies, Inc. - Pipeline by Stage of Development, 2016 8 Jyant Technologies, Inc. - Monotherapy Products in Pipeline, 2016 9 Jyant Technologies, Inc. - Phase II, 2016 10 Jyant Technologies, Inc. - Preclinical, 2016 11 Jyant Technologies, Inc. - Pipeline by Target, 2016 23 Jyant Technologies, Inc. - Pipeline by Route of Administration, 2016 24 Jyant Technologies, Inc. - Pipeline by Molecule Type, 2016 25 Jyant Technologies, Inc. - Pipeline Products by Mechanism of Action, 2016 26
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.